162 related articles for article (PubMed ID: 35929906)
1. LncRNA
Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X
Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
4. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MCM3AP-AS1 Regulates miR-21/PTEN Axis to Affect Cervical Squamous Cell Carcinoma Cell Proliferation and Apoptosis.
Yan G; Wan Z; Zhong Y; Chen M
Crit Rev Eukaryot Gene Expr; 2022; 32(4):49-56. PubMed ID: 35695665
[TBL] [Abstract][Full Text] [Related]
9. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
10. The MCM3AP-AS1/miR-126/VEGF axis regulates cancer cell invasion and migration in endometrioid carcinoma.
Yu J; Fan Q; Li L
World J Surg Oncol; 2021 Jul; 19(1):213. PubMed ID: 34256796
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
Luo H; Zhang Y; Qin G; Jiang B; Miao L
BMC Cancer; 2021 Jul; 21(1):820. PubMed ID: 34271873
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MCM3AP-AS1 is downregulated in atherosclerosis and sponges miR-448 to suppress vascular smooth muscle cell proliferation.
Liu S; Qin X
Medicine (Baltimore); 2023 Jun; 102(22):e33731. PubMed ID: 37266599
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer.
Yu CS; Wang YB; Li Q; Yang EL; Dong BB
J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
16. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
Ji L; Fan X; Zhou F; Gu J; Deng X
J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
Dai W; Zeng W; Lee D
J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
Yi D; Zhang D; He J
Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
